Hua?Medicine?(the?"Company",?Hong?Kong?Stock?Exchange?Stock?Code:?2552)?announced?yesterday?a?positive?profit?alert?for?the?first?half?of?the?year?for?the?Company?together?with?its?subsidiaries.?(the?"Group").
Hua?Medicine?("the?Company",?stock?code:?2552.HK)?announced?today?that?the?Company?presented?the?latest?research?results?of?dorzagliatin,?its?global?first-in-class?glucokinase?activator?(GKA),?at?the?85th?Scientific?Sessions?of?the?American?Diabetes?Association?(ADA).
Hua?Medicine?("the?Company",?stock?code:?2552.HK)?announced?today?that?it?will?present?the?research?results?of?dorzagliatin,?the?Company's?global?first-in-class?glucokinase?activator?(GKA),?at?the?85th?American?Diabetes?Association?(ADA)?Scientific?Sessions.?
ir@huamedicine.com
No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203
Privacy Statement Terms of Use
